Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CENPBD1P is a human pseudogene predicted to contain a DNA-binding domain similar to the centromere protein B (CENPB), but it does not encode a functional protein and is not described as having an established biological role[2][1]. Its designation as a pseudogene means it likely arose from duplication or mutation of a functional gene and was subsequently rendered non-coding. As a result, CENPBD1P is not considered a receptor, enzyme, or therapeutic target and is not known to interact with any drugs, nor does it participate in recognized molecular pathways, disease mechanisms, or clinical biomarkers[2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CENPB DNA-binding domain containing 1, pseudogene (CENPBD1P).